Original citation: J Clin Invest. 2016;126(8):3036–3052. https://doi.org/10.1172/JCI83416
Citation for this amendment: J Clin Invest. 2021;131(13):e152477. https://doi.org/10.1172/JCI152477
The Editors posted an Expression of Concern for this article following notification that two images in Figure 9D were subsequently published as distinct samples in another paper (1). An institutional review of the primary data supports that the images in the JCI article are correct and that no corrective action is required.
Version 1. 07/01/2021
Electronic publication
Footnotes
See the related article at Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.
References
- 1.Bielamowicz K, et al. Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma. Neuro Oncol. 2018;20(4):506–518. doi: 10.1093/neuonc/nox182. [DOI] [PMC free article] [PubMed] [Google Scholar]